HK1139049A1 - Use of a compound for the preparation of a medicament in treatment of antibiotic-resistant bacteria infection - Google Patents

Use of a compound for the preparation of a medicament in treatment of antibiotic-resistant bacteria infection

Info

Publication number
HK1139049A1
HK1139049A1 HK10104822.4A HK10104822A HK1139049A1 HK 1139049 A1 HK1139049 A1 HK 1139049A1 HK 10104822 A HK10104822 A HK 10104822A HK 1139049 A1 HK1139049 A1 HK 1139049A1
Authority
HK
Hong Kong
Prior art keywords
antibiotic
medicament
compound
preparation
treatment
Prior art date
Application number
HK10104822.4A
Other languages
English (en)
Inventor
Ming-Chu Hsu
Chi-Hsin Richard King
Shu-Jen Chen
Luke Lin
Original Assignee
Taigen Biotechnology Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taigen Biotechnology Co Ltd filed Critical Taigen Biotechnology Co Ltd
Publication of HK1139049A1 publication Critical patent/HK1139049A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
HK10104822.4A 2008-07-01 2010-05-17 Use of a compound for the preparation of a medicament in treatment of antibiotic-resistant bacteria infection HK1139049A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US7729308P 2008-07-01 2008-07-01

Publications (1)

Publication Number Publication Date
HK1139049A1 true HK1139049A1 (en) 2010-09-10

Family

ID=41464848

Family Applications (1)

Application Number Title Priority Date Filing Date
HK10104822.4A HK1139049A1 (en) 2008-07-01 2010-05-17 Use of a compound for the preparation of a medicament in treatment of antibiotic-resistant bacteria infection

Country Status (14)

Country Link
US (1) US8211909B2 (ko)
EP (1) EP2303271B1 (ko)
JP (1) JP2011526887A (ko)
KR (2) KR20150006080A (ko)
CN (1) CN101618038B (ko)
AU (1) AU2008358909B2 (ko)
CA (1) CA2728328C (ko)
EA (1) EA018653B1 (ko)
HK (1) HK1139049A1 (ko)
NZ (1) NZ588898A (ko)
TR (1) TR201820964T4 (ko)
TW (1) TWI375558B (ko)
WO (1) WO2010002415A1 (ko)
ZA (1) ZA201100616B (ko)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101392808B1 (ko) * 2011-12-30 2014-05-12 순천대학교 산학협력단 식물 추출물 또는 이의 분획물을 포함하는 항균용 조성물
CN103145615B (zh) * 2013-03-20 2015-07-29 浙江医药股份有限公司 一种奈诺沙星螯合物的后处理方法
KR101392810B1 (ko) * 2013-09-25 2014-05-12 순천대학교 산학협력단 된장풀 추출물 또는 이의 분획물을 포함하는 항균용 조성물
US9492374B2 (en) 2015-03-25 2016-11-15 Jose Rafael Salinas Andrade Composition and method for treatment of ulcers
CN105368825B (zh) * 2015-10-14 2019-09-10 华东医院 幽门螺杆菌抗生素耐药性分析试剂盒及耐药性检测方法
AU2018385789B2 (en) * 2017-12-11 2024-02-15 Denovamed Inc. 5-(2,5-bis(4-chloro-2-isopropylphenyl)thiophen-3-yl)-1H-tetrazole for the topical treatment of bacterial infections
CN111979292B (zh) * 2020-07-27 2022-08-05 广东省微生物研究所（广东省微生物分析检测中心） 一种同时携带多重耐药基因cfr和lsa(E)的MRSA的用途

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US100800A (en) 1870-03-15 Improvement in riding attachments for plows
US3989816A (en) 1975-06-19 1976-11-02 Nelson Research & Development Company Vehicle composition containing 1-substituted azacycloheptan-2-ones
US4444762A (en) 1980-04-04 1984-04-24 Nelson Research & Development Company Vehicle composition containing 1-substituted azacyclopentan-2-ones
US6387928B1 (en) * 1997-09-15 2002-05-14 The Procter & Gamble Co. Antimicrobial quinolones, their compositions and uses
SK286420B6 (sk) * 1997-09-15 2008-09-05 The Procter & Gamble Company Zlúčenina so štruktúrou chinolónu, farmaceutický prostriedok s jej obsahom a jej použitie
US6348624B1 (en) 1998-01-09 2002-02-19 The Procter & Gamble Co. Process for making certain benzoic acid compounds
HUP0303991A3 (en) 2000-12-14 2012-09-28 Warner Chilcott Company Cyclization process step in the making of quinolones and naphthyridines
US6900224B2 (en) * 2002-07-31 2005-05-31 The Procter & Gamble Company Antimicrobial quinolones, their compositions and uses
US6803469B2 (en) 2002-08-05 2004-10-12 The Procter & Gamble Company Process for preparing quinolone antibiotic intermediates
WO2005026145A2 (en) * 2003-09-12 2005-03-24 Warner-Lambert Company Llc Quinolone antibacterial agents
BRPI0709772B8 (pt) * 2006-03-28 2021-05-25 The Protecter & Gamble Company sais de malato e polimorfos do ácido (3s,5s)-7-[3-amino-5-metil-piperidinil]-1-ciclopropil-1,4-diidro-8-metóxi-4-oxo-3-quinolinocarboxílico
CA2647454A1 (en) 2006-03-28 2007-10-04 The Procter & Gamble Company A coupling process for preparing quinolone intermediates
US7528264B2 (en) 2006-03-28 2009-05-05 The Procter & Gamble Company Hydride reduction process for preparing quinolone intermediates
US8658183B2 (en) * 2007-08-09 2014-02-25 Taigen Biotechnology Company, Ltd. Antimicrobial parenteral formulation
JP2011528354A (ja) * 2008-07-15 2011-11-17 タイゲン バイオテクノロジー カンパニー，リミテッド 抗生物質

Also Published As

Publication number Publication date
KR20150006080A (ko) 2015-01-15
EA201170121A1 (ru) 2011-06-30
CN101618038A (zh) 2010-01-06
EA018653B1 (ru) 2013-09-30
CA2728328A1 (en) 2010-01-07
TW201002322A (en) 2010-01-16
JP2011526887A (ja) 2011-10-20
ZA201100616B (en) 2011-10-26
EP2303271A1 (en) 2011-04-06
EP2303271A4 (en) 2012-01-25
TR201820964T4 (tr) 2019-01-21
CA2728328C (en) 2015-02-24
KR20110044168A (ko) 2011-04-28
NZ588898A (en) 2012-09-28
TWI375558B (en) 2012-11-01
AU2008358909B2 (en) 2012-12-13
AU2008358909A1 (en) 2010-01-07
US8211909B2 (en) 2012-07-03
CN101618038B (zh) 2011-12-07
WO2010002415A1 (en) 2010-01-07
EP2303271B1 (en) 2018-11-07
US20100004282A1 (en) 2010-01-07

Similar Documents

Publication Publication Date Title
IL216605A (en) A pharmaceutical composition comprising 2-aryl-benzothiazole or 2-aryl-pyrido (d) thiazole, and its use in the preparation of a drug for the treatment of viral inflammation
IL213528A (en) Use of digestive enzymes in the preparation of a drug for the treatment of golden staphylococcal infections
ZA200906126B (en) Use of IL-23 antigonists for treatment of infection
IL205321A0 (en) Use of a composition comprising an electrochemically altered fluid for the treatment of bacterial infection
IL210589A (en) C2386RV Protein Tuberculosis Kvfb Protein Use for the Treatment or Prevention of TB
IL212064A (en) Use of pirpenidone in the preparation of a drug for the treatment of patients with atypical liver function
EP2273989A4 (en) POLYTHERAPY FOR THE TREATMENT OF BACTERIAL INFECTIONS
EP2450046A4 (en) MEDICALLY ACTIVE COMPOSITION FOR THE TREATMENT OF BRONCHITIS AND PREPARATION THEREOF
IL223783B (en) Compound 1-converted indole for use in the treatment of a disease or condition, a pharmaceutical preparation containing the compound and use of the compound to prepare a medicine
IL211120A (en) Compound, tetracycline converted at position 7c with fluorine, a pharmaceutical preparation containing it and its use in the preparation of drugs for the treatment of bacteria-caused infection
EP2440251A4 (en) INTERFERON ADMINISTRATION FOR PROPHYLAXIS AGAINST PATHOGEN INFECTION OR TREATMENT OF PATHOGEN INFECTION
ZA201100705B (en) Antibacterial combination therapy for the treatment of gram positive bacterial infections
HK1139049A1 (en) Use of a compound for the preparation of a medicament in treatment of antibiotic-resistant bacteria infection
IL236360A0 (en) Inhalable medicine
IL218283A (en) Use of a mixture of factors for the preparation of drugs for the treatment of diseases of proliferation
HK1167592A1 (en) Cycloundecadepsipeptide compounds and use of said compounds as a medicament
IL218302A (en) Use of compounds for the preparation of drugs for the treatment of acute voice trauma
IL213403A (en) Use of the IgG variant for the preparation of a drug for treating a patient with Staphylococcus aureus infection
EP2276505A4 (en) USE OF MATERIAL FOR MANUFACTURING A MEDICAMENT FOR TREATING A BANAL COLD
GB2435425B (en) Medical wound healing treatment
EP2465847A4 (en) AZETIDINONE COMPOUNDS AND THEIR MEDICAL USE
GB0603630D0 (en) Medical wound healing treatment
EP2431365A4 (en) AZETIDINE COMPOUND AND ITS MEDICAL USE
HK1138189A1 (en) Use of a compound in the manufacture of a medicament for the treatment of leukaemia
EP2271328A4 (en) ANTISEPTIC COMPOSITIONS FOR THE TREATMENT OF INFECTIONS